Targeting IL-6 Succeeds in Systemic JIA


Accordingly, a favorable outcome was seen in 69.5% of patients receiving this treatment, the researchers reported online in Pediatric Rheumatology. Systemic JIA is currently classified as one of the subtypes of JIA, although it is differentiated by having …

Read more